Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 14 Gastrointestinal 9 Genitourinary 5 Other hematologic neoplasm 3 Lymphoid 3 Thoracic 2 Plasma cell 2 Sarcoma 1 Head & Neck 1 Gynecologic 1 Endocrine 1 Dermatologic 1 Classical hematology 1

Conditions

Melanoma 2646 Lymphoma, T-Cell, Cutaneous 479 Skin Neoplasms 408 Carcinoma, Non-Small-Cell Lung 377 Mycosis Fungoides 330 Neoplasms 319 Keratosis, Actinic 300 Sezary Syndrome 294 Breast Neoplasms 285 Neoplasm Metastasis 284 Carcinoma, Renal Cell 280 Lymphoma, Non-Hodgkin 276 Lymphoma 263 Carcinoma, Basal Cell 262 Lymphoma, Large B-Cell, Diffuse 261 Leukemia, Lymphocytic, Chronic, B-Cell 261 Lymphoma, Follicular 259 Hodgkin Disease 247 Lymphoma, Mantle-Cell 245 Lymphoma, B-Cell, Marginal Zone 245 Precursor Cell Lymphoblastic Leukemia-Lymphoma 243 Uveal Melanoma 234 Burkitt Lymphoma 233 Lymphoma, Large-Cell, Immunoblastic 223 Colorectal Neoplasms 196 Lymphoma, Large-Cell, Anaplastic 190 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 186 Ovarian Neoplasms 181 Squamous Cell Carcinoma of Head and Neck 180 Lung Neoplasms 179

Interventions

Decision Support Techniques 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Patient Participation × Dermatologic × Clear all

NCT04240717 2022-11-07

PEF-Immun

University Hospital Heidelberg

Phase NA Completed

Melanoma, Patient Participation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡